Indium (111In) imciromab

Indium (111In) imciromabMonoclonal antibody

Type| Fab fragment
Source| Mouse
Target| cardiac myosin
Clinical data
Trade names| Myoscint
ATC code|

* V09GX02 (WHO)

Legal status
Legal status|

* withdrawn

Identifiers
CAS Number|

* 126132-83-0 N (imciromab)

ChemSpider|

* none

UNII|

* UT2BA2O3KN

NY (what is this?) (verify)

Indium (111In) imciromab (trade name Myoscint) is a mouse monoclonal antibody labelled with the radioisotope Indium-111.[1] It was used for cardiac imaging, but withdrawn in 1993.[2]

## See also

* Nuclear medicine

## References

1. ↑ WHO Drug Information
2. ↑ DiagnosticImaging.com: Centocor withdraws imaging agent applications

* v
* t
* e

Diagnostic radiopharmaceuticals (ATC: V09)

Central nervous system|

* 99mTc (Exametazime)
* 123I (Ioflupane
* Iofetamine
* Iomazenil)
* 18F (Florbetapir, Flutemetamol)

Skeletal system|

* 99mTc (Medronic acid)

Renal|

* 123I (Sodium iodohippurate)
* 64Cu (Cu-ETS2)

Gastrointestinal/Hepatic|

* 75Se (SeHCAT)

Respiratory system|

* 133Xe
* 81mKr
* 99mTc (99mTc-MAA)

Cardiovascular system|

* 99mTc (Sestamibi
* Tetrofosmin)
* 111In (Imciromab)
* 82Rb (Rubidium chloride)

Inflammation/infection|

* 99mTc (Exametazime
* Sulesomab
* Tilmanocept)
* 111In
* 67Ga

Tumor|

* 99mTc (Arcitumomab
* Votumumab
* Hynic-octreotide)
* 111In (Capromab pendetide
* Satumomab pendetide)
* 125I (Minretumomab)
* 123I / 131I (Iobenguane)
* 18F (Fluciclovine
* Fludeoxyglucose
* Fluoroethyltyrosine
* Sodium fluoride)

Adrenal cortex|

* 123I
* 125I / 131I (Iodocholesterol)

Radionuclides
(including tracers)|

| positron (PET list)|

* 11C ([11C]ME@HAPTHI
* 25B-NBOMe (Cimbi-36)
* Acetate
* Choline
* Carfentanil
* DASB
* DTBZ
* Flumazenil
* Methionine
* N-Methylspiperone
* Pittsburgh compound B
* Raclopride
* Verapamil)
* 13N (Ammonia)
* 15O (Water)
* 18F (Altanserin
* Desmethoxyfallypride
* FMISO
* Fallypride
* Florbetaben
* Florbetapir
* Flubatine
* Fluciclovine
* Fludeoxyglucose (18F) (FDG)-glucose analogue
* Flumazenil
* Fluorocholine
* Fluorodeoxysorbitol (FDS)
* Fluorodopa
* Fluorothymidine F-18
* Fluspidine
* Flutemetamol
* MPPF
* Mefway
* Nifene
* N-Methylspiperone
* FET
* Setoperone)
* 64Cu
* 68Ga
* 82Rb (Rubidium chloride)

|

gamma ray/photon (SPECT/scintigraphy)|

* 51Cr
* 57Co
* 67Ga
* 75Se
* 81mKr
* 99mTc
* 111In
* 123I
* 125I
* 131I
* 133Xe
* 153Sm
* 201Tl

* v
* t
* e

Monoclonals for bone, musculoskeletal, circulatory, and neurologic systems

Bone ("-os-", "-s(o)-")|

| Human ("-osu-")|

* Burosumab
* Denosumab

|

Humanized ("-sozu-")|

* Blosozumab
* Romosozumab

Musculoskeletal ("-mul-")|

| Human ("-mulu-")|

* Stamulumab†

|

Circulatory ("-c(i[r])-")|

| Human ("-ciru-")|

* Alirocumab
* Ascrinvacumab
* Enoticumab
* Evinacumab†
* Evolocumab
* Icrucumab
* Inclacumab
* Nesvacumab
* Orticumab
* Ramucirumab
* Rinucumab

|

Mouse ("-ciro-")|

* Biciromab‡
* Imciromab‡

Chimeric ("-cixi-")|

* Abciximab
* Volociximab

Humanized ("-cizu-")|

* Alacizumab pegol
* Bevacizumab/Ranibizumab
* Bococizumab
* Brolucizumab†
* Caplacizumab
* Demcizumab
* Etaracizumab
* Faricimab†
* Idarucizumab
* Ralpancizumab
* Tadocizumab
* Vanucizumab

Neurologic ("-ne(u)(r)-")|

| Human ("-neru-")|

* Aducanumab†
* Erenumab
* Fasinumab†
* Fulranumab
* Gantenerumab†
* Opicinumab

|

Humanized ("-nezu-"/"-neuzu-")|

* Bapineuzumab†
* Crenezumab†
* Eptinezumab
* Fremanezumab
* Galcanezumab
* Ozanezumab
* Ponezumab
* Refanezumab
* Solanezumab
* Tanezumab†

Angiogenesis inhibitor ("-anibi-")|

| Humanized ("-anibizu-")|

* Ranibizumab

|

Growth factor ("-gr(o)-")|

| Human ("-gru-")|

* Bimagrumab
* Trevogrumab

|

Humanized ("-grozu-")|

* Domagrozumab
* Landogrozumab

* #WHO-EM
* ‡Withdrawn from market
* Clinical trials:
* †Phase III
* §Never to phase III

0.00

(0 votes)

|

Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:Indium_(111In)_imciromab&oldid=530261"
*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template